Increased plasma FGF21 levels might be attributed to the fact that HDAC3 inhibition can prevent diabetes-induced liver damage and enhance FGF21 expression and circulating secretion, including in diabetic conditions [103]. This evidence concerns the gene FGF21 and diabetes mellitus.